Gday Mason - not sure if the below adds any value. I was just...

Gday Mason - not sure if the below adds any value. I was just trying to work out the various stages which seem to be embedded in the Assay development step. The reason I did this was because last time BD1 made announcements about the development of the AAB tests for ovarian there always seemed to be another hurdled to jump over ....I could never work out when we were going to get to clinical trials. there always seemed to be a validation or optimization or feasibility stage or further tweaking etc... Below I have taken info from the last two presentations and announcements and tried to decipher what was next for SubB2M. this was done prior to the Appendix 4E (which, by the way, i thought contained good insight and reflected positive momentum from the company). it will take a bit to digest but i tried to use colours to track the various stages through the 2 announcements....